Retinoids in superficial bladder tumours update.
D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D005050:Etretinate / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007633:Keratins / Q000037:antagonists & inhibitors; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D010212:Papilloma / Q000139:chemically induced / Q000188:drug therapy; D012878:Skin Neoplasms / Q000139:chemically induced / Q000188:drug therapy; D014212:Tretinoin / Q000031:analogs & derivatives / Q000494:pharmacology; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000188:drug therapy*
D014212:Tretinoin; D005050:Etretinate; D007633:Keratins; C010832:motretinide